Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse potential of IV remimazolam in recreational users
NCT04110535Phase 1Completed
- Sponsor
- PAION AG
- Start
- Jun 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of remimazolam in Procedural sedation (PS) (5 arms), sponsored by PAION AG. Primary endpoint: Drug Liking Visual Analog Scale Maximum Effect. Started Jun 2015; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04110535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04110535.